The biopharmaceutical industry is continuously undergoing organizational changes intended to better support the healthcare industries while maintaining quality and reducing cost. A new article by Allan Marinelli, for Pharmaceutical Online, illustrates how manufacturers can add value to their operations by using a quality validation Risk Management Approach for the development of sampling plans. Establishing a quality validation risk management approach for all pharmaceutical processes would increase the probability of successful outcomes for both the companies producing the products — by helping to meet regulatory requirements — while better contributing to the quality of healthcare for patients.
Posted by Dr. Tim Sandle
